Eflornithine is used to treat African trypanosomiasis (sleeping sickness) and to reduce unwanted facial hair growth in women. It inhibits ornithine decarboxylase, affecting polyamine synthesis essential for cell proliferation. It is grouped under the following drug class(es): Trypanosomiasis agents. Its therapeutic use is listed as anti-infectives, antiparasitics and antiprotozoals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Vaniqa, Difluoromethylornithine and Ornidyl. Its PubChem CID is 3009.
Eflornithine
| CAS No | 1069-31-4 |
|---|---|
| Molecular Formula | C6H12F2N2O2 |
| Molecular Weight | 182.17 g/mol |
| Synonyms | 2,5-diamino-2-(difluoromethyl)pentanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Eflornithine is used to treat African trypanosomiasis (sleeping sickness) and to reduce unwanted facial hair growth in women. It inhibits ornithine decarboxylase, affecting polyamine synthesis essential for cell proliferation.
The listed CAS number is 1069-31-4.
The listed molecular formula is C6H12F2N2O2.
The listed molecular weight is 182.17 g/mol.
2,5-diamino-2-(difluoromethyl)pentanoic acid.
The source lists Vaniqa, Difluoromethylornithine and Ornidyl.